XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Net Income Attributable to Shareholders of Crawford & Company per Common Share | 9 Months Ended
--- | ---
Sep. 30, 2022
Earnings Per Share [Abstract] |
Net Income Attributable to Shareholders of Crawford & Company per Common Share | 7. Net Income Attributable to Shareholders of Crawford & Company per Common Share The Company computes earnings per share of its non-voting Class A Common Stock ("CRD-A") and voting Class B Common Stock ("CRD-B") using the two-class method, which allocates the undistributed earnings in each period to each class on a proportionate basis. The Company's Board of Directors has the right, but not the obligation, to declare higher dividends on the CRD-A shares than on the CRD-B shares, subject to certain limitations. In periods when the dividend is the same for CRD-A and CRD-B or when no dividends are declared or paid to either class, the two-class method generally will yield the same earnings per share for CRD-A and CRD-B. During 2021 and 2022, the Board of Directors has declared the same dividend on CRD-A and CRD-B. The computations of basic net income attributable to shareholders of Crawford & Company per common share were as follows:
|  | Three Months Ended |  |  | Nine months ended |
|  | September 30, 2022 |  |  | September 30, 2021 |  |  | September 30, 2022 |  |  | September 30, 2021 |
(in thousands, except per share amounts) |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |
(Loss) earnings per share - basic: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allocation of undistributed (loss) earnings |  | $ | (10,647 | ) |  | $ | (7,401 | ) |  | $ | 4,632 |  |  | $ | 3,380 |  |  | $ | (7,797 | ) |  | $ | (5,359 | ) |  | $ | 11,257 |  |  | $ | 8,205 |
Dividends paid |  |  | 1,713 |  |  |  | 1,191 |  |  |  | 1,839 |  |  |  | 1,344 |  |  |  | 5,299 |  |  |  | 3,639 |  |  |  | 5,539 |  |  |  | 4,038 |
Net (loss) income attributable to common shareholders, basic |  | $ | (8,934 | ) |  | $ | (6,210 | ) |  | $ | 6,471 |  |  | $ | 4,724 |  |  | $ | (2,498 | ) |  | $ | (1,720 | ) |  | $ | 16,796 |  |  | $ | 12,243 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding, basic |  |  | 28,553 |  |  |  | 19,848 |  |  |  | 30,711 |  |  |  | 22,407 |  |  |  | 29,397 |  |  |  | 20,202 |  |  |  | 30,786 |  |  |  | 22,438 |
(Loss) earnings per share - basic |  | $ | (0.31 | ) |  | $ | (0.31 | ) |  | $ | 0.21 |  |  | $ | 0.21 |  |  | $ | (0.08 | ) |  | $ | (0.09 | ) |  | $ | 0.55 |  |  | $ | 0.55 |
The computations of diluted net income attributable to shareholders of Crawford & Company per common share were as follows:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, 2022 |  |  | September 30, 2021 |  |  | September 30, 2022 |  |  | September 30, 2021 |
(in thousands, except per share amounts) |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |
(Loss) earnings per share - diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allocation of undistributed (loss) earnings |  | $ | (10,647 | ) |  | $ | (7,401 | ) |  | $ | 4,710 |  |  | $ | 3,302 |  |  | $ | (7,797 | ) |  | $ | (5,359 | ) |  | $ | 11,428 |  |  | $ | 8,034 |
Dividends paid |  |  | 1,713 |  |  |  | 1,191 |  |  |  | 1,839 |  |  |  | 1,344 |  |  |  | 5,299 |  |  |  | 3,639 |  |  |  | 5,539 |  |  |  | 4,038 |
Net (loss) income attributable to common shareholders, diluted |  | $ | (8,934 | ) |  | $ | (6,210 | ) |  | $ | 6,549 |  |  | $ | 4,646 |  |  | $ | (2,498 | ) |  | $ | (1,720 | ) |  | $ | 16,967 |  |  | $ | 12,072 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding, basic |  |  | 28,553 |  |  |  | 19,848 |  |  |  | 30,711 |  |  |  | 22,407 |  |  |  | 29,397 |  |  |  | 20,202 |  |  |  | 30,786 |  |  |  | 22,438 |
Weighted-average effect of dilutive securities |  |  | — |  |  |  | — |  |  |  | 1,243 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,130 |  |  |  | — |
Weighted-average common shares outstanding, diluted |  |  | 28,553 |  |  |  | 19,848 |  |  |  | 31,954 |  |  |  | 22,407 |  |  |  | 29,397 |  |  |  | 20,202 |  |  |  | 31,916 |  |  |  | 22,438 |
(Loss) earnings per share - diluted |  | $ | (0.31 | ) |  | $ | (0.31 | ) |  | $ | 0.20 |  |  | $ | 0.21 |  |  | $ | (0.08 | ) |  | $ | (0.09 | ) |  | $ | 0.53 |  |  | $ | 0.54 |
Listed below are the shares excluded from the denominator in the preceding computation of diluted earnings per share for CRD-A because their inclusion would have been antidilutive:
|  | Three Months Ended |  | Nine Months Ended
(in thousands) |  | September 30, 2022 |  | September 30, 2021 |  | September 30, 2022 |  | September 30, 2021
Shares underlying stock options excluded |  | 1,542 |  | 352 |  | 1,542 |  | 706
Performance stock grants excluded because performance conditions have not been met (1) |  | 816 |  | 396 |  | 759 |  | 318
(1) Compensation cost is recognized for these performance stock grants based on expected achievement rates; however, no consideration is given to these performance stock grants when calculating diluted earnings per share until the performance measurements have been achieved. The following table details shares issued during the three and nine months ended September 30, 2022 and 2021, including restricted shares that were returned prior to vesting. These shares are included from their dates of issuance in the weighted-average common shares used to compute basic and diluted earnings per share for CRD-A in the table above. There were no shares of CRD-B issued during any of these periods.
|  | Three Months Ended |  |  | Nine Months Ended |
(in thousands) |  | September 30, 2022 |  |  | September 30, 2021 |  |  | September 30, 2022 |  |  | September 30, 2021 |
CRD-A issued under the Non-Employee Director Stock Plan |  |  | 5 |  |  |  | — |  |  |  | 99 |  |  |  | 67 |
CRD-A issued under the U.K. ShareSave Scheme |  |  | — |  |  |  | 5 |  |  |  | — |  |  |  | 70 |
CRD-A issued under the Employee Stock Purchase Plan |  |  | 124 |  |  |  | 159 |  |  |  | 124 |  |  |  | 159 |
CRD-A issued under the 2016 Omnibus Stock and Incentive Plan |  |  | — |  |  |  | — |  |  |  | (6 | ) |  |  | — |
Effective May 9, 2019, the Company's Board of Directors authorized the repurchase of up to 2,000,000 shares of CRD-A or CRD-B (or a combination of the two) through December 31, 2020 (the "2019 Repurchase Authorization"). The Company’s Board of Directors subsequently amended this authorization to allow for repurchases through December 31, 2021. Under the 2019 Repurchase Authorization, repurchases may be made for cash, in the open market or privately negotiated transactions at such times and for such prices as management deems appropriate, subject to applicable contractual and regulatory restrictions. At September 30, 2022, there were no remaining shares authorized to repurchase under the 2019 Repurchase Authorization. Effective November 4, 2021, the Company’s Board of Directors authorized the repurchase of up to 2,000,000 shares of CRD-A or CRD-B (or a combination of the two) through December 31, 2023 (the “2021 Repurchase Authorization”). On February 10, 2022, the Company's Board of Directors authorized the addition of 5,000,000 shares of CRD-A or CRD-B (or a combination of the two) to its 2021 Repurchase Authorization which had a remaining authorization to purchase 413,317 shares at December 31, 2021. Under the new repurchase program, repurchases may be made through December 31, 2023 in the open mar ket or privately negotiated transactions at such times and for such prices as management deems appropriate, subject to applicable regulatory guidelines. The new authorization does not obligate Crawford to acquire any stock, and purchases may be commenced or suspended at any time based on market conditions and other factors that the Company deems appropriate. At September 30, 2022, there were 1,793,371 remaining shares authorized to repurchase under the 2021 Repurchase Authorization. During the nine months ended September 30, 2022, the Company repurchased 2,656,474 shares of CRD-A and 963,472 shares CRD-B at an average cost of $7.41 and $7.32, respectively. During the nine months ended September 30, 2021, the Company repurchased 530,598 shares of CRD-A and 111,499 shares of CRD-B at an average cost of $9.63 and $8.68, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration